Atlas Trials

Treatment of Carrying TP53 Harmful Mutations

Clinical trial NCT03645200 · UNKNOWN

Trial details

NCT number
NCT03645200
Sponsor
Tianjin Medical University Second Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Cancer
Start date
2019-07-01
Primary completion
2019-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.